658 related articles for article (PubMed ID: 21259410)
1. The Tn antigen-structural simplicity and biological complexity.
Ju T; Otto VI; Cummings RD
Angew Chem Int Ed Engl; 2011 Feb; 50(8):1770-91. PubMed ID: 21259410
[TBL] [Abstract][Full Text] [Related]
2. The Cosmc connection to the Tn antigen in cancer.
Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
[TBL] [Abstract][Full Text] [Related]
3. Cosmc is an essential chaperone for correct protein O-glycosylation.
Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
6. Functional assays for the molecular chaperone cosmc.
Ju T; Cummings RD
Methods Enzymol; 2010; 479():107-22. PubMed ID: 20816162
[TBL] [Abstract][Full Text] [Related]
7. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
8. Protein glycosylation: chaperone mutation in Tn syndrome.
Ju T; Cummings RD
Nature; 2005 Oct; 437(7063):1252. PubMed ID: 16251947
[TBL] [Abstract][Full Text] [Related]
9. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
10. Cosmc transfection decreases malignant behavior of Tn
Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Sun X; Ju T; Cummings RD
BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
[TBL] [Abstract][Full Text] [Related]
12. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).
Arend P
Cancer Med; 2017 Jul; 6(7):1601-1613. PubMed ID: 28580709
[TBL] [Abstract][Full Text] [Related]
13. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
14. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
Ju T; Wang Y; Aryal RP; Lehoux SD; Ding X; Kudelka MR; Cutler C; Zeng J; Wang J; Sun X; Heimburg-Molinaro J; Smith DF; Cummings RD
Proteomics Clin Appl; 2013 Oct; 7(9-10):618-31. PubMed ID: 23857728
[TBL] [Abstract][Full Text] [Related]
15. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
[TBL] [Abstract][Full Text] [Related]
16. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.
Ju T; Cummings RD
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16613-8. PubMed ID: 12464682
[TBL] [Abstract][Full Text] [Related]
17. Cosmc-dependent mucin-type
Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.
Blixt O; Lavrova OI; Mazurov DV; Cló E; Kracun SK; Bovin NV; Filatov AV
Glycobiology; 2012 Apr; 22(4):529-42. PubMed ID: 22143985
[TBL] [Abstract][Full Text] [Related]
19. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
20. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
Ju T; Lanneau GS; Gautam T; Wang Y; Xia B; Stowell SR; Willard MT; Wang W; Xia JY; Zuna RE; Laszik Z; Benbrook DM; Hanigan MH; Cummings RD
Cancer Res; 2008 Mar; 68(6):1636-46. PubMed ID: 18339842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]